Cincinnati Children’s Opens State-of-the-Art Applied Cell & Gene Therapy Center

Cincinnati Children’s celebrated the opening of the new Applied Cell & Gene Therapy Center in Sharonville, Ohio this week. To expand its ability to deliver cutting-edge treatments for pediatric cancer, blood diseases, and genetic disorders, Cincinnati Children’s Hospital partnered with BHDP to design this state-of-the-art research facility.

This $60 million, 60,000-SF project functions as both a laboratory and advanced manufacturing site. Building on 15 years of in-house clinical trial drug production, the new space includes five Viral Vector and seven Cell Therapy ISO7 cGMP manufacturing suites, plus 10,000 SF for quality control and R&D labs. 

“This complex facility also features enhanced air filtration and temperature and humidity control, which is critical to the safety and manufacturing of these therapies,” said Don Elsen, Lead Architect at BHDP. “We are proud to be a part of the design team to help Cincinnati Children’s scale innovation and accelerate the delivery of life-changing therapies to children worldwide.”

With the research side operational, Cincinnati Children’s will now pursue certification, expected to take about a year, to ensure the center meets all requirements for gene, cell, and immunotherapy products manufacturing.

For more news, visit the Cincinnati Children’s website, Spectrum News One, PR Newswire, or Local 12.